Companies Dominating the Pain Patches Landscape
- Endo, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson and Johnson Private Limited
- Sorrento Therapeutics, Inc.
- Amneal Pharmaceuticals LLC
- Purdue Pharma L.P.
- Teva Pharmaceutical Industries Ltd.
- Grunenthal GmbH
- NEXGEL, Inc.
- Viatris Inc.
- Pfizer Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Amneal Pharmaceuticals, Inc. received US FDA approval for an Abbreviated New Drug Application (ANDA) for a generic version of Lidocaine Patch, 5%. The generic form of Lidoderm Patch, 5% is called Lidocaine Patch, 5%, and it is used to treat post-herpetic neuralgia.
- Teva Pharmaceutical Industries Ltd unveiled Flector1 Patch, 1.3 %, an authorized generic. The launch is a breakthrough addition to the company’s product portfolio of more than 40 generic pain management medicines.
